 | Adverum Biotechnologies (NASDAQ:ADVM) Downgraded to Hold at Zacks Investment Research
marketbeat.com - December 7 at 4:32 PM |
 | Adverum Biotechnologies Appoints Rupert D’Souza, Ph.D., M.B.A. as Chief Financial Officer
finance.yahoo.com - December 6 at 1:44 PM |
 | Contrasting Adaptive Biotechnologies (NASDAQ:ADPT) & Adverum Biotechnologies (NASDAQ:ADVM)
americanbankingnews.com - December 6 at 5:08 AM |
| Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Sees Significant Decrease in Short Interest
americanbankingnews.com - December 4 at 3:34 AM |
| Moore Kuehn, PLLC Encourages Investors of Adverum Biotechnologies, Inc. to Contact Law Firm
finance.yahoo.com - November 30 at 10:51 AM |
| Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives Consensus Rating of "Hold" from Analysts
americanbankingnews.com - November 26 at 11:36 AM |
| Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Expected to Post Earnings of -$0.42 Per Share
americanbankingnews.com - November 25 at 9:10 PM |
| Comparing aTyr Pharma (NASDAQ:LIFE) & Adverum Biotechnologies (NASDAQ:ADVM)
americanbankingnews.com - November 23 at 7:24 AM |
 | Independent Director James Scopa Just Sold A Bunch Of Shares In Adverum Biotechnologies, Inc. (NASDAQ:ADVM)
nasdaq.com - November 19 at 8:16 PM |
| Insider Selling: Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Director Sells 50,000 Shares of Stock
americanbankingnews.com - November 17 at 5:24 PM |
| Here's What Adverum Biotechnologies, Inc.'s (NASDAQ:ADVM) Shareholder Ownership Structure Looks Like
finance.yahoo.com - November 17 at 10:09 AM |
|
 | Adverum Biotechnologies, Inc.(ADVM)
fool.com - November 12 at 8:55 AM |
| Adverum Reports Third Quarter 2021 Results
finance.yahoo.com - November 4 at 8:38 PM |
| Adverum Presents Clinical Data on ADVM-022 at the American Society of Retina Specialists 39th Annual Scientific Meeting
finance.yahoo.com - October 9 at 2:40 PM |
| Adverum's Single Dose Wet AMD Gene Therapy Shows Robust Two Year Durability, Safety
finance.yahoo.com - October 4 at 12:39 PM |
| Companies Like Adverum Biotechnologies (NASDAQ:ADVM) Are In A Position To Invest In Growth
finance.yahoo.com - October 3 at 11:37 AM |
 | Adverum Biotechnologies Shares Up on Favorable Long-Term Data for ADVM-022
marketwatch.com - October 2 at 12:31 AM |
| Adverum Presents 2-Year OPTIC Data Demonstrating Sustained Durability and Promising Safety Profile from Single Intravitreal Injection of ADVM-022 in Wet AMD Patients Who Previously Required Frequent Anti-VEGF Injections
finance.yahoo.com - October 1 at 7:30 PM |
| Adverum to Present Data from ADVM-022 Clinical Trials at Upcoming Medical Conferences
finance.yahoo.com - September 27 at 9:05 AM |
| Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulatory Affairs
finance.yahoo.com - August 23 at 11:47 AM |
| Bullish insiders at Adverum Biotechnologies, Inc. (NASDAQ:ADVM) loaded up on US$613k of stock earlier this year
nasdaq.com - August 22 at 3:20 PM |
| Insiders might want to re-evaluate their US$613k stock purchase as Adverum Biotechnologies, Inc. (NASDAQ:ADVM) drops to US$217m
finance.yahoo.com - August 19 at 7:25 AM |
| Why Adverum Biotechnologies (ADVM) Might Surprise This Earnings Season
finance.yahoo.com - August 6 at 2:19 PM |
| Adverum Reports Second Quarter 2021 Results
finance.yahoo.com - August 5 at 6:52 PM |
 | Where Adverum Biotechnologies Stands With Analysts
benzinga.com - July 23 at 8:17 PM |
| Adverum Provides Update on ADVM-022 and the INFINITY Trial in Patients with Diabetic Macular Edema
finance.yahoo.com - July 22 at 6:21 PM |
| Understanding Adverum Biotechnologies's Unusual Options Activity
benzinga.com - July 22 at 12:27 AM |
| Adverum Announces Appointment of Jon Williams, Ph.D., as Vice President, Clinical Affairs
finance.yahoo.com - July 1 at 9:45 AM |
| Adverum Biotechnologies (ADVM) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - June 28 at 5:38 PM |
| If You Had Bought Adverum Biotechnologies' (NASDAQ:ADVM) Shares A Year Ago You Would Be Down 85%
finance.yahoo.com - June 21 at 7:27 AM |
| Why Adverum Biotechnologies Stock Sank in May
finance.yahoo.com - June 15 at 7:38 AM |
| Adverum Appoints CMO and CSO
finance.yahoo.com - June 1 at 8:53 AM |
| Are Options Traders Betting on a Big Move in Adverum (ADVM) Stock?
finance.yahoo.com - May 18 at 11:31 AM |
| Adverum Biotechnologies (ADVM) is Oversold: Can It Recover?
finance.yahoo.com - May 17 at 12:39 PM |
|
 | Adverum Biotechnologies Stock Is Estimated To Be Possible Value Trap
uk.finance.yahoo.com - May 16 at 6:31 AM |
| Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual Meeting
finance.yahoo.com - May 12 at 4:06 PM |
| The Sonic Fund II, L.P. Comments on Preliminary Voting Results of Adverum Annual Meeting
finance.yahoo.com - May 12 at 4:06 PM |
| The Sonic Fund II, L.P. Issues Statement to Adverum Stockholders
finance.yahoo.com - May 11 at 6:17 PM |
| The Sonic Fund II, L.P. Reminds Adverum Stockholders to Vote for Its Three Independent Director Nominees at May 12 Annual Meeting
finance.yahoo.com - May 10 at 2:13 PM |
| Adverum Issues Statement Regarding Upcoming Annual Meeting of Stockholders
finance.yahoo.com - May 10 at 9:12 AM |
| Adverum Biotechnologies'(NASDAQ:ADVM) Share Price Is Down 81% Over The Past Year.
nasdaq.com - May 9 at 1:53 PM |
| Adverum Biotechnologies (ADVM) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 6 at 10:03 PM |
| Adverum Reports First Quarter 2021 Results
finance.yahoo.com - May 6 at 5:02 PM |
| Glass Lewis Joins ISS In Recommending Adverum Shareholders Vote for All Three Independent Sonic Director Nominees
finance.yahoo.com - May 6 at 12:02 PM |
 | Adverum Biotechnologies: One Adverse Event Too Many
seekingalpha.com - May 4 at 7:00 PM |
| ISS Recommends Adverum Stockholders Vote to Elect Sonic’s Three Independent, Highly Qualified Nominees
finance.yahoo.com - May 4 at 8:51 AM |
| Adverum's Wet AMD Gene Therapy Shows Long Term Benefit In Treatment-Experienced Patients
finance.yahoo.com - May 3 at 1:07 PM |
 | BRIEF-The Sonic Fund Ii, L.P. Comments On Adverum Update Regarding Infinity Phase 2 Trial Of Advm-022
msn.com - April 29 at 4:15 PM |
| Why Adverum Biotechnologies Stock Is Imploding Today
finance.yahoo.com - April 29 at 4:15 PM |
| The Sonic Fund II, L.P. Comments on Adverum Biotechnologies Update Regarding INFINITY Phase 2 Trial of ADVM-022
finance.yahoo.com - April 29 at 4:15 PM |
| Adverum's Stock Crashes After DME Gene Therapy Trial Derails On One Patient's Serious Adverse Event
finance.yahoo.com - April 29 at 9:36 AM |
